Efficacy and Safety of 12-Week Coblopasvir/Sofosbuvir Regimen for Hepatitis C in Northwest China: A Multi-Center Prospective Study.

coblopasvir (KW 136) - Beijing Kawin

Sovaldi (sofosbuvir) - Gilead

http://www.ncbi.nlm.nih.gov/pubmed/42159424

Fanpu Ji; Fuchun Jing; Hong Du; Hong Jiang; Jiuping Wang; Longdong Zhu; Lu Yan; Maimaitiaili Tuerxun; Maimaitijiang Wubuliaishan; Mingbo Yang; Xiangchun Ding; Xiaohong Gao; Xiaoni Kou; Ye Zhang; Yingli He

May 21, 2026